FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

779557009: Product containing only insulin aspart and insulin degludec in parenteral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3740818016 Insulin aspart and insulin degludec only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3740819012 Product containing only insulin aspart and insulin degludec in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3740818016 Insulin aspart and insulin degludec only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3740819012 Product containing only insulin aspart and insulin degludec in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5566721000241111 produit contenant seulement de l'insuline asparte et de l'insuline dégludec sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5566721000241111 produit contenant seulement de l'insuline asparte et de l'insuline dégludec sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Insulin aspart and insulin degludec only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. insulina aspartat true Inferred relationship Existential restriction modifier (core metadata concept) 1
Insulin aspart and insulin degludec only product in parenteral dose form Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart and insulin degludec only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Insulin degludec true Inferred relationship Existential restriction modifier (core metadata concept) 2
Insulin aspart and insulin degludec only product in parenteral dose form Is a Insulin aspart- and insulin degludec-containing product in parenteral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart and insulin degludec only product in parenteral dose form Is a Insulin aspart and insulin degludec only product true Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart and insulin degludec only product in parenteral dose form Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start